EMEA-000165-PIP01-07

  • Email
  • Help

Overview

Product details for Janumet
Invented nameJanumet
Active substance

Sitagliptin phosphate monohydrate, metformin hydrochloride

Decision numberP/114/2008
PIP numberEMEA-000165-PIP01-07
Pharmaceutical form(s)Film-coated tablet
Condition(s)/indication(s)

Type 2 Diabetes Mellitus

Route(s) of administrationOral use
PIP applicant

Merck Sharp and Dohme (Europe), Inc.
Belgium
E-mail: pip.information@merck.com
Tel. +31 412663179
Fax +31 412662571

Decision typeW: decision granting a waiver in all age groups for the listed condition(s)

Decision

Related information